Europe Drugmaker Profits Set to Hit Record Versus Market: ChartBy
After their worst quarter in eight years, health-care companies in the Stoxx Europe 600 Index are enjoying their biggest weekly gains since February. While deal speculation has been on the rise, there’s more to the rally. Analysts, who predict profit declines for the region, are more bullish on the industry, sending their projections for drugmakers’ earnings to a record high relative to the broader market, according to data going back to 2005.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.